Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Assets (2016 - 2025)

Historic Return on Assets for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Q4 2025 value amounting to 0.23%.

  • Enanta Pharmaceuticals' Return on Assets rose 500.0% to 0.23% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.23%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.25% for FY2025, which is 300.0% up from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Return on Assets stood at 0.23% for Q4 2025, which was up 500.0% from 0.28% recorded in Q3 2025.
  • Enanta Pharmaceuticals' Return on Assets' 5-year high stood at 0.19% during Q1 2021, with a 5-year trough of 0.37% in Q1 2023.
  • Over the past 5 years, Enanta Pharmaceuticals' median Return on Assets value was 0.29% (recorded in 2025), while the average stood at 0.28%.
  • In the last 5 years, Enanta Pharmaceuticals' Return on Assets tumbled by -2300bps in 2021 and then skyrocketed by 600bps in 2024.
  • Quarter analysis of 5 years shows Enanta Pharmaceuticals' Return on Assets stood at 0.26% in 2021, then fell by -28bps to 0.33% in 2022, then increased by 7bps to 0.31% in 2023, then increased by 7bps to 0.29% in 2024, then rose by 19bps to 0.23% in 2025.
  • Its last three reported values are 0.23% in Q4 2025, 0.28% for Q3 2025, and 0.29% during Q2 2025.